{
    "clinical_study": {
        "@rank": "126188", 
        "arm_group": [
            {
                "arm_group_label": "acetaminophen", 
                "arm_group_type": "Active Comparator", 
                "description": "1g intravenous acetaminophen over a period of 15 minutes, 15 minutes (+/- 10 minutes) prior to the anticipated time of incision and every 6 hours (+/- 30 minutes) after the initial dose for 24 hours; maximum dose of 4 grams in 24 hours"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo \t0.9% NaCl 100 mL over will be administered intravenously over a period of 15 minutes, 15 minutes (+/- 10 minutes) prior to the anticipated time of incision and every 6 hours (+/- 30 minutes) after the initial dose for 24 hours"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this project is to study the effects of preoperative followed by scheduled\n      intravenous acetaminophen on pain control for 24 hours postoperatively after minimally\n      invasive 1 or 2 level transforaminal lumbar interbody fusion."
        }, 
        "brief_title": "Postoperative Opioid Use and Pain Scores in Patients Undergoing Transforaminal Lumbar Interbody Fusion After Administration of Preoperative Followed by Scheduled Intravenous Acetaminophen:", 
        "condition": "Transforaminal Lumbar Interbody Fusion", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age > 18 years old\n\n          -  Being scheduled to have elective primary minimally invasive 1 or 2  level\n             transforaminal lumbar laminectomy interbody fusion\n\n          -  ASA I, II, or III\n\n          -  Informed consent form signed\n\n        Exclusion Criteria:\n\n          -  Anyone weighing less than 50kg (as this would require a dosing change).\n\n          -  Hypersensitivity or contraindication to intravenous acetaminophen or opioids\n\n          -  Allergy to Methocarbamol; morphine sulfate, sevoflourane, or fentanyl\n\n          -  Impairment of liver function-- defined as the inability to receive intravenous\n             acetaminophen without dose adjustment as determined by the investigator; or history\n             of chronic liver disease defined as history of hepatitis of any kind as recorded in\n             the patient's chart\n\n          -  Mental retardation recorded as a diagnosis in the patient's chart\n\n          -  History of chronic pain (defined as currently receiving treatment from a specialist\n             for pain)\n\n          -  History of pain recalcitrant to intravenous morphine\n\n          -  Impaired kidney function (defined as creatinine > 1.5)\n\n          -  Anyone who is not a candidate for general anesthesia or any other portion of the\n             investigator's standard of"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 11, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02061774", 
            "org_study_id": "L14-015"
        }, 
        "intervention": {
            "arm_group_label": "acetaminophen", 
            "description": "1 gram of intravenous Acetaminophen", 
            "intervention_name": "Acetaminophen", 
            "intervention_type": "Drug", 
            "other_name": "Tylenol"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Acetaminophen", 
                "Analgesics, Opioid"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": "effects of preoperative followed by scheduled intravenous acetaminophen in transforaminal lumbar interbody fusion", 
        "lastchanged_date": "February 12, 2014", 
        "location": {
            "contact": {
                "email": "thu.fenno@ttuhsc.edu", 
                "last_name": "Thu Fenno", 
                "phone": "806-743-4222", 
                "phone_ext": "223"
            }, 
            "facility": {
                "address": {
                    "city": "Lubbock", 
                    "country": "United States", 
                    "state": "Texas", 
                    "zip": "79430"
                }, 
                "name": "Texas Tech University Health Science Center"
            }, 
            "investigator": {
                "last_name": "Jaime Villarreal, MD", 
                "role": "Sub-Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Postoperative Opioid Use and Pain Scores in Patients Undergoing Transforaminal Lumbar Interbody Fusion After Administration of Preoperative Followed by Scheduled Intravenous Acetaminophen: A Prospective, Randomized, Double Blind, Placebo-controlled Trial", 
        "overall_contact": {
            "email": "thu.fenno@ttuhsc.edu", 
            "last_name": "Thu Fenno", 
            "phone": "8067434222", 
            "phone_ext": "223"
        }, 
        "overall_official": {
            "affiliation": "TTUHSC department of Surgery", 
            "last_name": "Jason Felton, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The Visual Analogue Scale (VAS) and Verbal Rating Scale (VRS) will be measured at 4 hour intervals for a 24-hr period - measures of pain intensity in clinical and research settings", 
            "measure": "VAS", 
            "safety_issue": "No", 
            "time_frame": "Q4 x 24 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02061774"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Sedation will be measured on a scale of 1 to 5 at 4-hour intervals as follows: 1-completely awake; 2-awake but drowsy; 3 asleep, but responds to verbal commands; 4-asleep but responds to tactile stimuli; and 5-asleep and not responding to any stimuli.", 
                "measure": "Sedation", 
                "safety_issue": "Yes", 
                "time_frame": "4-hr intervals for a 24-hr period"
            }, 
            {
                "description": "Routine postoperative vital signs will be collected at 4-hour intervals (+/- 30 minutes) postoperatively respiratory rate, oxygen saturation, mean arterial pressure, and heart rate. Any reports of headache, dizziness, nausea, vomiting, pruritis, agitation, constipation, insomnia, bradycardia (Heart rate below 60 beats per minute), hypotension (MAP less than 30% of baseline), or urinary retention will be recorded throughout the study and will be treated appropriately as they occur, and the treatment medication will be stopped if determined to be a causative factor.", 
                "measure": "Vital signs", 
                "safety_issue": "Yes", 
                "time_frame": "4-hour intervals (+/- 30 minutes)  for 24-hrs"
            }
        ], 
        "source": "Texas Tech University Health Sciences Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Texas Tech University Health Sciences Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}